The weakening effect of soluble epoxide hydrolase inhibitor AUDA on febrile response to lipopolysaccharide and turpentine in rat
Open Access
- 24 July 2017
- journal article
- research article
- Published by Springer Nature in Journal of Physiology and Biochemistry
- Vol. 73 (4) , 551-560
Abstract
A still growing body of evidence suggests the importance of epoxyeicosatrienoic acids (EETs) in the regulation of inflammatory response; therefore, drugs that stabilize their levels by targeting the soluble epoxide hydrolase (sEH), an enzyme responsible for their metabolism, are currently under investigation. The effect of sEH inhibitors on molecular components of fever mechanism, i.e., on synthesis of pro-inflammatory cytokines or prostaglandins, has been repeatedly proven; however, the hypothesis that sEH inhibitors affect febrile response has never been tested. The aim of this study was to examine if sEH inhibition affects core body temperature (Tb) as well as Tb changes during febrile response to infectious (lipopolysaccharide; LPS) or non-infectious (turpentine; TRP) stimuli. Male Wistar rats were implanted intra-abdominally with miniature biotelemeters to monitor Tb. A potent sEH inhibitor 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA) was suspended in olive oil and administrated into animals in the intraperitoneal (i.p.) dose of 15 mg/kg, which, as we showed, has no significant influence on normal Tb. We have found that AUDA injected 3 h after LPS (50 μg/kg i.p.) significantly weakened febrile rise of Tb. Moreover, injection of sEH inhibitor 7 h after turpentine (administrated subcutaneously in a dose of 100 μL/rat) markedly reduced the peak period of aseptic fever. Obtained results provide first experimental evidence that sEH inhibitors possess anti-pyretic properties. Therefore, medicines targeting sEH enzymatic activity should be considered as a complement to the arsenal of topical medications used to treat fever especially in clinical situations when non-steroidal anti-inflammatory drugs are ineffective.Keywords
Funding Information
- Uniwersytet Mikolaja Kopernika w Toruniu (2253-B)
This publication has 42 references indexed in Scilit:
- Soluble Epoxide Hydrolase Activity Determines the Severity of Ischemia-Reperfusion Injury in KidneyPLOS ONE, 2012
- Discovery of Inhibitors of Soluble Epoxide Hydrolase: A Target with Multiple Potential Therapeutic IndicationsJournal of Medicinal Chemistry, 2011
- Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMPProceedings of the National Academy of Sciences, 2011
- Epoxygenated Fatty Acids and Soluble Epoxide Hydrolase Inhibition: Novel Mediators of Pain ReductionJournal of Agricultural and Food Chemistry, 2010
- 14,15-Epoxyeicosatrienoic acid induces vasorelaxation through the prostaglandin EP2 receptors in rat mesenteric arteryProstaglandins & Other Lipid Mediators, 2010
- Soluble Epoxide Inhibition Is Protective Against Cerebral Ischemia via Vascular and Neural ProtectionThe American Journal of Pathology, 2009
- Angiotensin II AT1 blockade reduces the lipopolysaccharide-induced innate immune response in rat spleenAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathwaysProceedings of the National Academy of Sciences, 2008
- Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolaseBioorganic & Medicinal Chemistry, 2007
- Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitorsProceedings of the National Academy of Sciences, 2006